Equities
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)22.50
  • Today's Change0.22 / 0.99%
  • Shares traded8.84m
  • 1 Year change-21.00%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai Fosun Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the research and development, manufacturing and sales of pharmaceutical products. The Company operates in five segments. Pharmaceutical segment is mainly engaged in the manufacturing of innovative drugs, mature pharmaceutical products and vaccines. Medical Devices and Medical Diagnostics segment is mainly engaged in the manufacturing and sales of medical cosmetic devices such as molecular diagnosis, immunodiagnosis, and microbial diagnosis. Medical Health Services segment is mainly engaged in the operation of an online and offline integrated medical service platform. Pharmaceutical Distribution and Retail segment is mainly engaged in the wholesale and retail of pharmaceutical products. Others segment is engaged in other pharmaceutical-related businesses. The Company's products are mainly used in the treatment of tumors, immunity, central nervous system and other fields.

  • Revenue in CNY (TTM)40.47bn
  • Net income in CNY1.83bn
  • Incorporated1995
  • Employees40.37k
  • Location
    Shanghai Fosun Pharmaceutical Group Co LtdBuilding A, No. 1289 Yishan RoadSHANGHAI 200233ChinaCHN
  • Phone+86 2 133987870
  • Fax+86 2 133987871
  • Websitehttps://www.fosunpharma.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
600196:SHH since
announced
Transaction
value
Shanghai Rehabilitation Equity Investment Fund Management Co LtdDeal completed30 Oct 202330 Oct 2023Deal completed-19.87%3.04m
Data delayed at least 15 minutes, as of Sep 19 2024.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd8.10bn921.94m26.77bn4.62k22.413.28--3.311.191.1910.508.140.72752.783.171,753,354.008.138.9613.6112.8044.4540.8211.1810.671.26--0.189756.93-0.32665.2814.4911.93-4.3342.22
Bluestar Adisseo Co14.12bn626.36m27.14bn2.73k43.331.79--1.920.23360.23365.265.650.65495.037.545,163,249.002.915.283.526.9426.3130.314.448.761.086.120.098921.81-9.262.92-95.82-43.752.74-19.09
Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd76.59bn3.79bn38.05bn28.05k10.581.11--0.49682.332.3347.1122.311.016.354.672,730,601.005.295.909.9212.4017.4018.705.235.561.20--0.311530.026.6812.322.253.3427.7512.05
Beijing Tiantan Biological Products Corp5.33bn1.27bn41.33bn4.86k32.564.01--7.750.64190.64192.705.220.36740.9077222.801,097,335.0011.8611.7117.1116.5053.5449.3932.2827.713.23--0.007416.6721.5712.0625.9916.8529.6738.97
Beijing Tongrentang Co Ltd17.86bn1.70bn42.80bn16.78k25.133.21--2.401.241.2413.029.720.59161.1412.611,064,742.008.418.2016.2016.1745.2546.5914.2213.331.90--0.18630.9316.194.6816.928.03-12.0113.97
Shanghai Fosun Pharmaceutical (Group)40.47bn1.83bn53.10bn40.37k32.441.27--1.310.68670.686715.1517.570.35552.824.721,002,407.002.114.313.657.0146.4850.715.9310.650.7295--0.379931.92-5.8110.69-36.04-2.5010.95-3.34
Sichuan Biokin Pharmaceutical Co Ltd5.80bn4.21bn65.98bn2.09k15.6613.66--11.3710.5110.5114.4712.041.311.6743.232,782,145.0095.23--141.91--95.86--72.61--2.89--0.2027---20.11---176.40------
Data as of Sep 19 2024. Currency figures normalised to Shanghai Fosun Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

8.75%Per cent of shares held by top holders
HolderShares% Held
Perseverance Asset Management LPas of 30 Jan 202347.62m2.25%
E Fund Management Co., Ltd.as of 30 Jun 202431.90m1.51%
China Merchants Fund Management Co., Ltd.as of 31 Dec 202325.12m1.19%
UBS Asset Management Switzerland AGas of 30 Jan 202320.10m0.95%
Caitong Fund Management Co., Ltd.as of 30 Jan 202313.57m0.64%
Yinhua Fund Management Co., Ltd.as of 31 Dec 202311.60m0.55%
Huatai-PineBridge Fund Management Co., Ltd.as of 31 Dec 20239.80m0.46%
China Universal Asset Management Co., Ltd.as of 31 Dec 20239.15m0.43%
GF Fund Management Co., Ltd.as of 31 Dec 20239.06m0.43%
Tian Hong Asset Management Co., Ltd.as of 31 Dec 20237.42m0.35%
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.